List your tool

Head to head · 2026

Abridge vs Hippocratic AI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Abridge

Deployed at 300+ health systems, now backed by a strategic investment from Eli Lilly

4.5Not listed

Visit Abridge (opens Abridge in a new tab)

Hippocratic AI

115 million patient interactions with zero safety incidents, and it still won't diagnose

4.3Not listed

Visit Hippocratic AI (opens Hippocratic AI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Abridge does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Abridge

    4.5 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onAbridgeHippocratic AI
Our rating4.5Better4.3
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Ambient listening that turns patient-clinician conversations into structured notes
  • Deployed at Mayo Clinic, Duke Health, Johns Hopkins, and 300+ health systems
  • #1 Best in KLAS for Ambient AI in Revenue Cycle Management, two years running
  • Expanding beyond documentation into billing and clinical decision support
  • Roughly $830M raised, $5.3B valuation as of its Series E extension
  • Patient-facing AI agents for pre-visit intake, follow-up, and check-ins
  • Deliberately restricted from prescribing or diagnosing by design
  • 115 million-plus clinical patient interactions with no reported safety issues
  • Partnerships with 50+ health systems, payers, and pharmaceutical companies
  • $126M Series C at a $3.5B valuation in November 2025
Pros
  • Exceptional enterprise validation at some of the most prominent health systems
  • Strong, sustained KLAS recognition specifically for ambient AI quality
  • Expanding scope beyond documentation adds value without switching platforms
  • Non-diagnostic scope reduces liability risk compared to diagnostic AI agents
  • Massive interaction volume with a clean safety record builds real trust
  • Strong recent funding at a high valuation supports continued expansion
Cons
  • Enterprise pricing requires a sales conversation, no published self-serve rate
  • Built for large health system deployments, less suited to a solo practitioner
  • Broadening scope into billing and trial screening adds platform complexity to evaluate
  • Enterprise pricing requires a sales conversation, no published self-serve rate
  • Deliberately limited scope means it won't replace diagnostic or prescribing tools
  • Young company, founded 2023, with a shorter track record than established competitors
CompanyAbridge, founded 2018Hippocratic AI, founded 2023

Prices come from each vendor's pricing page, last checked 20260714. Check the vendor before you buy.

FAQ

Questions people ask

Is Abridge better than Hippocratic AI?

In our reviews Abridge scores 4.5 and Hippocratic AI scores 4.3. The better pick depends on the job. Abridge: Deployed at 300+ health systems, now backed by a strategic investment from Eli Lilly. Hippocratic AI: 115 million patient interactions with zero safety incidents, and it still won't diagnose.

Which is cheaper, Abridge or Hippocratic AI?

Abridge: see pricing. Hippocratic AI: see pricing.

Do Abridge and Hippocratic AI have free plans?

Neither lists a free plan.

More comparisons